Skip to main content

TD Global Healthcare Leaders Index ETF(TDOC-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: TD Global Healthcare Leaders Index ETF up on Monday (TDOC)

AI-generated - The Globe and Mail - Mon Nov 20, 2023

In trading today, TD Global Healthcare Leaders Index ETF shares opened at $16.80 and closed at $16.85. prices ranged from $16.77 to $16.85.

Share prices advanced 0.90 percent from the previous day's close of $16.70.

Today across North America, the TSX Composite closed 0.61% at 20175.77, the S&P 500 closed 0.13% at 4514.02, the Dow Jones Industrial Average closed 0.01% at 34947.28 and the Nasdaq Composite closed 0.08% at 14125.48.

TD Global Healthcare Leaders Index ETF has listed on the Toronto Stock Exchange (TSX) under the ticker TDOC.

Trading volume was 6,200 on 12 total trades, while having an average volume of 3,643 over 5 days.

Trading across the entire TSX saw 3,189 price advancers against 2,046 declines and 127 unchanged.

During the prior 52 weeks, TDOC.TO has traded as high as $18.02 (April 24,2023) and low as $16.02 (October 30,2023). Moreover, the shares have raised 0.48 percent in 52 weeks, while this year, they have dipped -1.86%.

Following today's trading, TD Global Healthcare Leaders Index ETF has a market capitalization of $56.78 million on a float of 3,400 shares outstanding. Its annual EPS is $None.

TD Global Healthcare Leaders Index ETF is a None company headquartered in, None.

The TD Global Healthcare Leaders Index ETF seeks to track, to the extent reasonably possible and before the deduction of fees and expenses, the performance of a global equity index which measures the investment return of global issuers related to healthcare. Currently, this TD ETF seeks to track the Solactive Global Healthcare Leaders Index (CA NTR) (or any successor thereto), which tracks the performance of securities of global large and mid-capitalization issuers that are related to healthcare..

Based on 0.00 analysts, TD Global Healthcare Leaders Index ETF gets an average recommendation of "Strong Sell" according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..